Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian Vala Nahed, M.D.

Co-Author

This page shows the publications co-authored by Brian Nahed and Jorg Dietrich.
Connection Strength

0.874
  1. Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa031.
    View in: PubMed
    Score: 0.216
  2. Bone marrow response as a potential biomarker of outcomes in glioblastoma patients. J Neurosurg. 2017 Jul; 127(1):132-138.
    View in: PubMed
    Score: 0.170
  3. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol. 2016 May; 127(3):505-14.
    View in: PubMed
    Score: 0.162
  4. Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis. Nat Commun. 2021 10 12; 12(1):5954.
    View in: PubMed
    Score: 0.060
  5. A rapid genotyping panel for detection of primary central nervous system lymphoma. Blood. 2021 08 05; 138(5):382-386.
    View in: PubMed
    Score: 0.059
  6. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults. J Neurooncol. 2020 Nov; 150(2):165-213.
    View in: PubMed
    Score: 0.057
  7. Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 Aug; 26(8):1309.
    View in: PubMed
    Score: 0.055
  8. Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 08; 26(8):1280-1284.
    View in: PubMed
    Score: 0.055
  9. Remote acute demyelination after focal proton radiation therapy for optic nerve meningioma. J Clin Neurosci. 2015 Aug; 22(8):1367-9.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.